GLP-1 drugs could have a surprisingly large environmental payoff
GLP-1 drugs could cut food demand enough to free farmland larger than Italy.
GLP-1 weight-loss medicines, including Ozempic and Wegovy, may impact more than just the body mass index of users, according to new research. If these appetite-suppressing medications become widely adopted, they could potentially reshape the global food system and release extensive amounts of agricultural land. The global food system operates on the principle of demand.
If individuals consume fewer calories, food producers will adjust their strategies, influencing production rates, pricing, trade dynamics, and the amount of land required. Utilizing a sophisticated computer simulation, researchers examined various scenarios, from GLP-1 usage limited to high-income nations to universal access. In the case of widespread GLP-1 usage among adults with obesity, the study estimates that reduced calorie consumption could prevent up to 6.6 million premature deaths by 2050.
Moreover, the research suggests that these weight-loss drugs could free up as much as 32 million hectares of agricultural land, an area larger than Italy, for alternative purposes.
Rewritten by urgent.news; may contain errors — check the original.
Source: arstechnica.com
This story
This is one outlet's version. Read the fullest account.
- GLP-1 drugs could have a surprisingly large environmental payoff arstechnica.com